AngioDynamics, Inc.
US ˙ NasdaqGS ˙ US03475V1017

SecurityANGO / AngioDynamics, Inc.
InstitutionJacobs Levy Equity Management, Inc
Latest Disclosed Ownership218,382 shares
Latest Disclosed Value $ 2,483,003
Jacobs Levy Equity Management, Inc ownership in ANGO / AngioDynamics, Inc.

On May 15, 2026 - Jacobs Levy Equity Management, Inc filed a 13F-HR form disclosing ownership of 218,382 shares of AngioDynamics, Inc. (US:ANGO) valued at $2,483,003 USD as of March 31, 2026. The entity filed a previous 13F-HR on August 14, 2025 disclosing 0 shares of AngioDynamics, Inc.. The current value of the position is $2,627,135 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F ANGIODYNAMICS COM 03475V101 218,382 218,382 2,483 0.0104
2025-08-14 2025-06-30 13F ANGIODYNAMICS COM 03475V101 0 -38,900 -100.00 0 -100.00
2025-05-15 2025-03-31 13F ANGIODYNAMICS COM 03475V101 38,900 -483,049 -92.55 365 -92.37 0.0014
2025-02-14 2024-12-31 13F ANGIODYNAMICS COM 03475V101 521,949 107,829 26.04 4,781 48.43 0.0169
2024-11-14 2024-09-30 13F ANGIODYNAMICS COM 03475V101 414,120 -95,157 -18.68 3,222 4.54 0.0124
2024-08-14 2024-06-30 13F ANGIODYNAMICS COM 03475V101 509,277 -176,763 -25.77 3,081 -23.49 0.0127
2024-05-15 2024-03-31 13F ANGIODYNAMICS COM 03475V101 686,040 -156,261 -18.55 4,027 -39.01 0.0180
2024-02-14 2023-12-31 13F ANGIODYNAMICS COM 03475V101 842,301 128,402 17.99 6,604 26.54 0.0333
2023-11-17 2023-09-30 13F ANGIODYNAMICS COM 03475V101 713,899 274,210 62.36 5,219 13.81 0.0309
2023-08-14 2023-06-30 13F ANGIODYNAMICS COM 03475V101 439,689 217,252 97.67 4,586 99.43 0.0264
2023-05-15 2023-03-31 13F ANGIODYNAMICS COM 03475V101 222,437 204,628 1,149.01 2,300 838.37 0.0141
2023-02-14 2022-12-31 13F ANGIODYNAMICS COM 03475V101 17,809 17,809 245 0.0017
2022-08-15 2022-06-30 13F ANGIODYNAMICS COM 03475V101 0 -20,742 -100.00 0 -100.00
2022-05-16 2022-03-31 13F ANGIODYNAMICS COM 03475V101 20,742 -64,848 -75.77 447 -81.07 0.0030
2022-02-14 2021-12-31 13F ANGIODYNAMICS COM 03475V101 85,590 -3,258 -3.67 2,361 2.43 0.0158
2021-11-15 2021-09-30 13F ANGIODYNAMICS COM 03475V101 88,848 0 0.00 2,305 -4.36 0.0155
2021-08-16 2021-06-30 13F ANGIODYNAMICS COM 03475V101 88,848 -21,374 -19.39 2,410 -6.55 0.0163
2021-05-17 2021-03-31 13F ANGIODYNAMICS COM 03475V101 110,222 -81,154 -42.41 2,579 -12.10 0.0199
2021-02-16 2020-12-31 13F ANGIODYNAMICS COM 03475V101 191,376 15,799 9.00 2,934 38.59 0.0257
2020-11-16 2020-09-30 13F ANGIODYNAMICS COM 03475V101 175,577 175,577 2,117 0.0219
2020-05-15 2020-03-31 13F ANGIODYNAMICS COM 03475V101 0 -35,597 -100.00 0 -100.00
2020-02-14 2019-12-31 13F ANGIODYNAMICS COM 03475V101 35,597 35,597 570 0.0056
2019-02-14 2018-12-31 13F ANGIODYNAMICS COM 03475V101 0 -23,864 -100.00 0 -100.00
2018-11-14 2018-09-30 13F ANGIODYNAMICS COM 03475V101 23,864 -191,214 -88.90 519 -89.15 0.0074
2018-08-14 2018-06-30 13F ANGIODYNAMICS COM 03475V101 215,078 630 0.29 4,783 29.31 0.0752
2018-05-15 2018-03-31 13F ANGIODYNAMICS COM 03475V101 214,448 21,402 11.09 3,699 15.23 0.0616
2018-02-13 2017-12-31 13F ANGIODYNAMICS COM 03475V101 193,046 58,632 43.62 3,210 39.75 0.0564
2017-11-14 2017-09-30 13F ANGIODYNAMICS COM 03475V101 134,414 -9,600 -6.67 2,297 -1.59 0.0447
2017-11-09 2017-06-30 13F/A-1 ANGIODYNAMICS COM 03475V101 144,014 -15,902 -9.94 2,334 -15.89 0.0499
2017-08-14 2017-06-30 13F ANGIODYNAMICS COM 03475V101 144,014 -15,902 2,334
2017-05-12 2017-03-31 13F ANGIODYNAMICS COM 03475V101 159,916 -1,400 -0.87 2,775 1.98 0.0561
2017-02-14 2016-12-31 13F ANGIODYNAMICS COM 03475V101 161,316 139,116 626.65 2,721 599.49 0.0525
2016-11-14 2016-09-30 13F ANGIODYNAMICS COM 03475V101 22,200 -1,300 -5.53 389 15.09 0.0069
2016-08-15 2016-06-30 13F ANGIODYNAMICS COM 03475V101 23,500 0 0.00 338 16.96 0.0070
2016-05-16 2016-03-31 13F ANGIODYNAMICS COM 03475V101 23,500 23,500 0.00 289 0.0061
2015-02-17 2014-12-31 13F ANGIODYNAMICS COM 03475V101 0 -11,599 -100.00 0 -100.00
2014-11-14 2014-09-30 13F ANGIODYNAMICS COM 03475V101 11,599 -20,315 -63.66 159 -69.48 0.0027
2014-08-14 2014-06-30 13F ANGIODYNAMICS COM 03475V101 31,914 31,914 -5.49 521 36.75 0.0086
2013-11-14 2013-09-30 13F ANGIODYNAMICS COM 03475V101 0 -33,767 -100.00 0 -100.00
2013-08-14 2013-06-30 13F ANGIODYNAMICS COM 03475V101 33,767 33,767 381 0.0067
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.